Dyadic International Inc (DYAI)
1.50
+0.01
(+0.67%)
USD |
NASDAQ |
Apr 24, 16:00
Dyadic International Total Liabilities (Quarterly): 2.341M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.341M |
| September 30, 2023 | 1.603M |
| June 30, 2023 | 2.089M |
| March 31, 2023 | 2.007M |
| December 31, 2022 | 2.625M |
| September 30, 2022 | 2.607M |
| June 30, 2022 | 3.662M |
| March 31, 2022 | 2.135M |
| December 31, 2021 | 2.909M |
| September 30, 2021 | 1.963M |
| June 30, 2021 | 3.288M |
| March 31, 2021 | 2.594M |
| December 31, 2020 | 1.626M |
| September 30, 2020 | 1.751M |
| June 30, 2020 | 1.638M |
| March 31, 2020 | 1.136M |
| December 31, 2019 | 1.588M |
| September 30, 2019 | 1.277M |
| June 30, 2019 | 1.450M |
| March 31, 2019 | 1.274M |
| Date | Value |
|---|---|
| December 31, 2018 | 0.8496M |
| September 30, 2018 | 0.8357M |
| June 30, 2018 | 0.4664M |
| March 31, 2018 | 0.9954M |
| December 31, 2017 | 0.7689M |
| September 30, 2017 | 1.066M |
| June 30, 2017 | 1.243M |
| March 31, 2017 | 1.235M |
| December 31, 2016 | 1.010M |
| September 30, 2016 | 0.596M |
| June 30, 2016 | 2.776M |
| March 31, 2016 | 1.296M |
| December 31, 2015 | 2.873M |
| September 30, 2015 | 13.41M |
| December 31, 2014 | 10.80M |
| March 31, 2014 | 12.38M |
| December 31, 2013 | 12.37M |
| September 30, 2013 | 11.33M |
| June 30, 2013 | 11.13M |
| March 31, 2013 | 10.67M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.136M
Minimum
Mar 2020
3.662M
Maximum
Jun 2022
2.120M
Average
2.007M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 9.147M |
| Perspective Therapeutics Inc | 22.71M |
| Protalix BioTherapeutics Inc | 50.86M |
| Electromed Inc | 6.622M |
| Armata Pharmaceuticals Inc | 130.43M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.219M |
| Shareholders Equity (Quarterly) | 5.879M |
| Current Ratio | 3.583 |